Open access
Oct 2026
FDXR upregulation by p63/p73 is a prognostic and therapeutic marker of adult T-cell leukemia/lymphoma
The findings establish FDXR as a novel biomarker of HTLV-1-associated disease progression and ATL prognosis, elucidate its upstream molecular regulation, and highlight its predictive potential for chemotherapeutic sensitivity of ATL cells.
Lara Gallucci, M. Josephine, Yasunori Kogure et al.
· EMBO Molecular Medicine · 0 citations